These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8328786)
21. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease. Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138 [TBL] [Abstract][Full Text] [Related]
22. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. Araújo MS; Martins-Filho OA; Pereira ME; Brener Z J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436 [TBL] [Abstract][Full Text] [Related]
23. Cytoskeleton reassembly in cardiomyocytes infected by Trypanosoma cruzi is triggered by treatment with ergosterol biosynthesis inhibitors. Silva DT; de Nazareth S L de Meirelles M; Almeida D; Urbina JA; Pereira MC Int J Antimicrob Agents; 2006 Jun; 27(6):530-7. PubMed ID: 16713188 [TBL] [Abstract][Full Text] [Related]
24. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice. Diniz LF; Mazzeti AL; Caldas IS; Ribeiro I; Bahia MT Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555633 [TBL] [Abstract][Full Text] [Related]
25. Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Urbina JA; Payares G; Sanoja C; Molina J; Lira R; Brener Z; Romanha AJ Int J Antimicrob Agents; 2003 Jan; 21(1):39-48. PubMed ID: 12507836 [TBL] [Abstract][Full Text] [Related]
26. Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas disease. Bahia MT; Nascimento AF; Mazzeti AL; Marques LF; Gonçalves KR; Mota LW; Diniz Lde F; Caldas IS; Talvani A; Shackleford DM; Koltun M; Saunders J; White KL; Scandale I; Charman SA; Chatelain E Antimicrob Agents Chemother; 2014 Aug; 58(8):4362-70. PubMed ID: 24841257 [TBL] [Abstract][Full Text] [Related]
28. Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments. Diniz Lde F; Urbina JA; de Andrade IM; Mazzeti AL; Martins TA; Caldas IS; Talvani A; Ribeiro I; Bahia MT PLoS Negl Trop Dis; 2013; 7(8):e2367. PubMed ID: 23967360 [TBL] [Abstract][Full Text] [Related]
29. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322 [TBL] [Abstract][Full Text] [Related]
30. Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging. Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM Antimicrob Agents Chemother; 2015 Aug; 59(8):4653-61. PubMed ID: 26014936 [TBL] [Abstract][Full Text] [Related]
31. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii. Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo effects of itraconazole against Trypanosoma cruzi. McCabe RE; Remington JS; Araujo FG Am J Trop Med Hyg; 1986 Mar; 35(2):280-4. PubMed ID: 3006529 [TBL] [Abstract][Full Text] [Related]
33. Ergosterol biosynthesis and drug development for Chagas disease. Urbina JA Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():311-8. PubMed ID: 19753490 [TBL] [Abstract][Full Text] [Related]
34. In vivo effects of terbinafine and ketoconazole on testosterone plasma levels in healthy males. Effendy I; Krause W Dermatologica; 1989; 178(2):103-6. PubMed ID: 2924980 [TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Gupta AK; Kohli Y Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235 [TBL] [Abstract][Full Text] [Related]